PHARMACEUTICAL MANUFACTURING BUSINESS GROWTH
Grow your pharmaceutical manufacturing business with the right opportunities
HCPA helps pharmaceutical manufacturers identify suitable clients, strengthen their market position and pursue partnerships and supply contracts that fit their manufacturing capabilities.

Growth in pharmaceutical manufacturing needs to align with what your facility, licence and manufacturing capabilities can reliably support. The strongest opportunities are usually those that fit your approved activities, technical capability, available capacity and ability to deliver consistently.
HCPA can help you identify and pursue opportunities that fit both your commercial goals and the capabilities of your operation.
Work with a senior consultant embedded in your leadership team
Your senior consultant brings deep experience across regulated industries, working alongside your leadership team to support strategic decisions, operational improvement and sustainable growth.
Draw on the experience of 200+ industry consultants
Benefit from the collective regulatory, operational and commercial experience of our team of 200+ consultants, helping you identify risks, avoid common growth mistakes and make better-informed decisions.

$2.1B+
Apply insights from 16,000 businesses we have supported
We bring practical insights from supporting 16,000 businesses across regulated industries, whose businesses have collectively generated more than $3.8 billion in revenue.

Completion
Action Required





16,000+ Businesses are growing faster
First Client Guarantee
Grow with regulatory confidence

Completion
Action Required





16,000+ Businesses are growing faster
First Client Guarantee

$2.1B+

Completion
Action Required





16,000+ Businesses are growing faster
First Client Guarantee
Where can pharmaceutical manufacturing growth come from?
Australia has a substantial medical science ecosystem, with more than 1,200 pharmaceutical and medical technology companies, creating a broad base for manufacturing partnerships, commercialisation and contract opportunities.
For manufacturers, the opportunity is to identify the organisations and products that best align with what the facility can reliably manufacture.
For established pharmaceutical importers, growth can come from adding the right products, strengthening overseas supplier relationships and building more effective Australian distribution channels.
Target contract manufacturing clients
Pharmaceutical companies, sponsors and biotechnology businesses may need manufacturing partners with the right technical capability and regulatory systems.
Focus on organisations whose product requirements align with your approved manufacturing activities, equipment, validated processes and available capacity.
Build commercialisation partnerships
Manufacturing can form part of a broader product-development or commercialisation partnership, particularly where a business needs to move from development or clinical-stage production towards commercial supply.
Clearly communicating your manufacturing scope, technical capabilities and available capacity helps potential partners assess whether your operation is the right fit.
Pursue supply contract opportunities
Long-term pharmaceutical manufacturing supply contracts can provide recurring production volume where your facility can demonstrate the required capability, capacity, quality systems and reliability.
Prospective clients may assess technical capability, experience, financial capacity, compliance, risk and commercial terms before entering an ongoing supply arrangement.
Turn manufacturing opportunities into sustainable growth
A stronger pharmaceutical manufacturing growth strategy can help your business work towards:
more qualified contract manufacturing opportunities
stronger pharmaceutical and biotechnology partnerships
long-term manufacturing supply contracts
greater recurring manufacturing revenue
better utilisation of available production capacity
stronger client retention and repeat work
growth supported by sufficient technical and regulatory capacity
HCPA can help you identify which clients, partnerships and supply opportunities best fit your existing capabilities and what may need to change before you pursue the next stage of growth.
Is your pharmaceutical manufacturing business ready to grow?
Do you have enough production capacity?
Does your licence cover the required activities?
Can your equipment and processes support the proposed product and volume?
Can your quality systems and trained personnel support greater production?
Can your suppliers and working capital support increased demand?
Will the opportunity deliver an appropriate commercial return?
Not sure if your pharmaceutical manufacturing business is ready to grow or scale? HCPA can assess your current capacity, identify what may need strengthening and help determine the right next step.

How HCPA supports pharmaceutical manufacturing growth
Growing a regulated manufacturing business means your commercial strategy needs to work alongside your technical, operational and compliance capabilities.
As production volumes and client requirements increase, so can the demands on equipment, personnel, validation, quality systems, suppliers and working capital. HCPA helps you consider these factors together so growth does not outpace the operation supporting it.
Identify growth opportunities
HCPA assesses your manufacturing capabilities, available capacity and target markets to identify the clients and opportunities that best fit your operation.
Strengthen your market position
We help clarify your target clients, manufacturing proposition, capabilities and partnership pathways so prospective customers can understand where you add value.
Prepare your operation to scale
HCPA considers capacity, equipment, licensing, validation and quality systems alongside commercial growth so the operation can support additional clients and production.
How HCPA helps you grow and scale sustainably
Assess your current position
Review your manufacturing scope, clients, capacity, market position and current operational and regulatory foundations.
Identify growth opportunities
Assess target clients, partnership opportunities and supply contracts to identify where growth best fits your manufacturing capabilities.
Develop the growth strategy
Build a practical plan around pharmaceutical manufacturing marketing, client targeting, positioning, partnerships and commercial priorities.
Prepare for growth
Strengthen capacity, equipment, quality systems and regulatory foundations, then implement and refine the strategy as the business scales.
HCPA’s First Client Guarantee
Backed by HCPA’s First Client Guarantee
For eligible businesses, HCPA’s support extends beyond developing the growth strategy. Once your business is operational, HCPA works with you to secure your first paying client within 12 months.
What does sustainable pharmaceutical manufacturing growth look like?
Australia’s medical science manufacturing sector increased its gross value by 12.9% over five years, highlighting the opportunity for manufacturers that can scale successfully.
For pharmaceutical manufacturers, sustainable growth means increasing production and commercial opportunities while maintaining the systems needed to deliver consistently.
Increasing capacity can create new revenue opportunities, but operational and quality systems need to keep pace with that growth.
HCPA can help you work towards:
qualified client and partnership opportunities
long-term manufacturing supply contracts
recurring manufacturing revenue
capacity utilisation
margin by product or contract
client retention and repeat work
The goal is to build a stronger pipeline of commercially valuable manufacturing work while maintaining the technical, quality and regulatory capability needed to deliver it.
Frequently asked questions about pharmaceutical manufacturing growth
How can a pharmaceutical manufacturer market its capabilities to attract suitable clients?
Start by defining the products and manufacturing activities your facility is best positioned to support.
Your pharmaceutical manufacturing marketing should clearly communicate your manufacturing scope, technical capabilities, validated processes, expertise and available capacity.
Then focus your business development on pharmaceutical companies, sponsors and other organisations whose product requirements align with those capabilities.
HCPA can help you identify suitable target markets and build a structured approach to pursuing the right clients and partnerships.
What does a pharmaceutical manufacturer need to demonstrate to secure long-term supply contracts?
Prospective clients need confidence that you can manufacture their product consistently, compliantly and at the required scale.
They may consider your technical capability, capacity, experience, quality systems, financial strength, supply reliability, risk management and commercial terms.
Your proposition should demonstrate both the value of the commercial arrangement and your ability to deliver it reliably over time.
What should a pharmaceutical manufacturing marketing strategy include?
Your strategy should define the clients and products your facility is best positioned to support, then communicate the capabilities that make your operation relevant to those opportunities.
This can include your manufacturing scope, technical expertise, validated processes, available capacity, positioning and approach to building relationships with prospective clients, sponsors and partners.
The goal is to generate relevant manufacturing opportunities, not simply more enquiries.
How can a pharmaceutical manufacturer differentiate itself?
Focus on capabilities your operation can genuinely demonstrate, such as specialist manufacturing activities, particular product types, available capacity, validated processes or technical expertise.
The strongest position connects a genuine client need with something your facility can reliably deliver.
Do GMP systems affect my ability to win manufacturing contracts?
Yes. Prospective clients need confidence that products can be manufactured consistently and to the required quality standards.
Strong Good Manufacturing Practice (GMP) systems can therefore support both regulatory compliance and commercial credibility.
Can increasing manufacturing capacity help attract larger clients?
Potentially. Greater production capacity can allow the business to pursue larger volumes and new manufacturing opportunities.
Before relying on that additional capacity, consider whether equipment, processes, staffing, validation and quality systems are ready to support it.
HCPA can help assess what needs to change before the operation takes on greater production volume.
How can a manufacturer assess whether a supply contract is a good growth opportunity?
Consider whether the product fits your manufacturing scope, whether you have sufficient capacity and whether the expected contract value and margin justify the operational commitment.
You should also assess equipment requirements, validation, staffing, supplier capacity, working capital and any regulatory changes needed before committing.
Can pharmaceutical manufacturers grow without adding new manufacturing capabilities?
Yes. Growth may come from improving capacity utilisation, securing additional production from existing clients, attracting new clients that fit your current scope or developing longer-term supply relationships.
Expanding capability should be considered where there is a clear commercial opportunity that justifies the additional investment and regulatory work.
How can a pharmaceutical manufacturer scale without creating GMP problems?
Make sure technical and quality capacity grow alongside production volume.
Equipment, personnel, validation, documentation, quality systems and management oversight all need to remain effective as the manufacturing operation becomes busier or more complex.
Related pharmaceutical importing resources
Starting your manufacturing business
Ready to start your pharmaceutical manufacturing business?
Managingongoing compliance
Need help keeping your manufacturing operation compliant?
Strengthen quality systems, validation, batch records, quality control and operating processes to maintain GMP compliance and prepare for ongoing TGA oversight.
Stay compliantWhat Our Clients Say

